EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human germline biallelic loss-of-function OSMR variants cause severe allergic disease

Simran Samra iD, Mehul Sharma iD, Julia Körholz iD, Yihui Liu iD, Alyssa James iD, Christina Michalski iD, Pariya Yousefi iD, Kate L Del Bel iD, Henry Y Lu iD, Ashish A Sharma iD, Maja Tarailo-Graovac iD, Joshua Dalmann iD und 38 weitere

Journal of Human Immunity · 06.07.2026 · 2 (4)

DOI: 10.70962/jhi.20260067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 28.05.2026. Verfasst von Simran Samra und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, Canadian Institutes of Health Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncostatin M (OSM) receptor beta (OSMRβ), encoded by OSMR, is a cytokine receptor subunit required for signaling by OSM and IL-31. We identified 10 affected individuals from seven unrelated families with germline biallelic loss-of-function variants in OSMR who shared a phenotype of early-onset, severe, widespread atopic dermatitis with peripheral eosinophilia and markedly elevated serum IgE. All patient-derived OSMRβ variants failed to localize to the cell surface, resulting in selective loss of OSM-dependent signaling. Patient cells showed markedly reduced OSM-induced phosphorylation of STAT1, STAT3, and STAT5, while signaling through other IL-6 family receptor complexes remained intact. Transcriptomic profiling of patient primary dermal fibroblasts revealed consistent downstream effects, including loss of interferon-responsive and inflammatory gene programs. Re-expression of wild-type OSMR restored receptor surface expression, STAT activation, and transcriptional responses, confirming a causal loss-of-function mechanism. Together, these findings establish biallelic OSMR deficiency as a novel primary atopic disorder.

Autor:innen und Institutionen

  • Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, Canada.
  • Experimental Medicine Program, Department of Medicine, The University of British Columbia, Vancouver, Canada.
  • Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • German Center for Child and Adolescent Health, Partner Site Leipzig/Dresden, Dresden, Germany.
  • Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Department of Pathology, Emory University, Atlanta, GA, USA.

ORCID-Profile: Simran Samra, Mehul Sharma, Julia Körholz, Yihui Liu, Alyssa James, Christina Michalski, Pariya Yousefi, Kate L Del Bel, Henry Y Lu, Ashish A Sharma, Maja Tarailo-Graovac, Joshua Dalmann, Lily Buder, Bhavi Modi, Ralf Wiedemuth, Liam Golding, Britt Drögemöller, Géraldine Blanchard-Rohner, Christof Senger, Wingfield Rehmus, Julie S Prendiville, Massimo Mangino, Colin J Ross, Clara D M van Karnebeek, Wyeth W Wasserman, Sergio D Rosenzweig, Julie Niemela, Pascal M Lavoie, P M Prathibha, Oliver Wegehaupt, Catherine M Biggs, Michael Boehnke, Leena Kinnunen, Heikki A Koistinen, Margaret L McKinnon, Jonas Maximillian Breuer, Jana Schönenkorb, Robert Brock, Sarah Thull, Christian Netzer, Clara Velmans, Norah Altuwaijri, Issam R Hamadah, Ruqaiah Altassan, Ahmed Alfares, Sateesh Maddirevula, Siddaramappa Jagdish Patil, Diana K Bayer, Jonathan J Lyons, Stuart E Turvey

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • Canadian Institutes of Health Research
  • Genome British Columbia
  • BC Children’s Hospital Foundation
  • Jeffery Modell Foundation
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Samra, S., Sharma, M., Körholz, J., Liu, Y., James, A., Michalski, C., Yousefi, P., Del Bel, K. L., Lu, H. Y., Sharma, A. A., Tarailo-Graovac, M., Dalmann, J., Buder, L., Modi, B., Wiedemuth, R., Golding, L., Drögemöller, B., Blanchard-Rohner, G., Senger, C., …, & Turvey, S. E. (2026). Human germline biallelic loss-of-function OSMR variants cause severe allergic disease. Journal of Human Immunity, 2(4). https://doi.org/10.70962/jhi.20260067

Vancouver

Samra S, Sharma M, Körholz J, Liu Y, James A, Michalski C, et al. Human germline biallelic loss-of-function OSMR variants cause severe allergic disease. Journal of Human Immunity. 2026;2(4). doi:10.70962/jhi.20260067

BibTeX
@article{Samra2026,
  author = {Samra, Simran and Sharma, Mehul and Körholz, Julia and Liu, Yihui and James, Alyssa and Michalski, Christina and Yousefi, Pariya and Del Bel, Kate L and Lu, Henry Y and Sharma, Ashish A and Tarailo-Graovac, Maja and Dalmann, Joshua and Buder, Lily and Modi, Bhavi and Wiedemuth, Ralf and Golding, Liam and Drögemöller, Britt and Blanchard-Rohner, Géraldine and Senger, Christof and Rehmus, Wingfield and Prendiville, Julie S and Mangino, Massimo and Ross, Colin J and van Karnebeek, Clara D M and Wasserman, Wyeth W and D Rosenzweig, Sergio and Niemela, Julie and Lavoie, Pascal M and Prathibha, P M and Wegehaupt, Oliver and Biggs, Catherine M and Boehnke, Michael and Kinnunen, Leena and Koistinen, Heikki A and McKinnon, Margaret L and Breuer, Jonas Maximillian and Schönenkorb, Jana and Brock, Robert and Thull, Sarah and Netzer, Christian and Velmans, Clara and Altuwaijri, Norah and Hamadah, Issam R and Altassan, Ruqaiah and Alfares, Ahmed and Maddirevula, Sateesh and Patil, Siddaramappa Jagdish and Bayer, Diana K and Lyons, Jonathan J and Turvey, Stuart E},
  title = {Human germline biallelic loss-of-function OSMR variants cause severe allergic disease},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {4},
  doi = {10.70962/jhi.20260067}
}
Kostenlos starten →